vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and WYNDHAM HOTELS & RESORTS, INC. (WH). Click either name above to swap in a different company.
WYNDHAM HOTELS & RESORTS, INC. is the larger business by last-quarter revenue ($334.0M vs $208.9M, roughly 1.6× iRhythm Holdings, Inc.). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs -18.0%, a 20.6% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs -76.3%). WYNDHAM HOTELS & RESORTS, INC. produced more free cash flow last quarter ($168.0M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs -4.6%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
Wyndham Hotels & Resorts, Inc., is an American hospitality company based in Parsippany, New Jersey, United States. It describes itself as the largest hotel franchisor in the world, with 9,100 locations.
IRTC vs WH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $334.0M |
| Net Profit | $5.6M | $-60.0M |
| Gross Margin | 70.9% | — |
| Operating Margin | 1.1% | — |
| Net Margin | 2.7% | -18.0% |
| Revenue YoY | 27.1% | -76.3% |
| Net Profit YoY | 518.5% | -170.6% |
| EPS (diluted) | $0.18 | $-0.80 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $334.0M | ||
| Q4 25 | $208.9M | $334.0M | ||
| Q3 25 | $192.9M | $382.0M | ||
| Q2 25 | $186.7M | $397.0M | ||
| Q1 25 | $158.7M | $316.0M | ||
| Q4 24 | $164.3M | $336.0M | ||
| Q3 24 | $147.5M | $396.0M | ||
| Q2 24 | $148.0M | $367.0M |
| Q1 26 | — | $-60.0M | ||
| Q4 25 | $5.6M | $-60.0M | ||
| Q3 25 | $-5.2M | $105.0M | ||
| Q2 25 | $-14.2M | $87.0M | ||
| Q1 25 | $-30.7M | $61.0M | ||
| Q4 24 | $-1.3M | $85.0M | ||
| Q3 24 | $-46.2M | $102.0M | ||
| Q2 24 | $-20.1M | $86.0M |
| Q1 26 | — | — | ||
| Q4 25 | 70.9% | — | ||
| Q3 25 | 71.1% | — | ||
| Q2 25 | 71.2% | — | ||
| Q1 25 | 68.8% | — | ||
| Q4 24 | 70.0% | — | ||
| Q3 24 | 68.8% | — | ||
| Q2 24 | 69.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.1% | -11.4% | ||
| Q3 25 | -4.4% | 46.6% | ||
| Q2 25 | -10.0% | 37.8% | ||
| Q1 25 | -20.5% | 35.4% | ||
| Q4 24 | -2.5% | 38.4% | ||
| Q3 24 | -34.1% | 43.2% | ||
| Q2 24 | -15.5% | 39.5% |
| Q1 26 | — | -18.0% | ||
| Q4 25 | 2.7% | -18.0% | ||
| Q3 25 | -2.7% | 27.5% | ||
| Q2 25 | -7.6% | 21.9% | ||
| Q1 25 | -19.3% | 19.3% | ||
| Q4 24 | -0.8% | 25.3% | ||
| Q3 24 | -31.3% | 25.8% | ||
| Q2 24 | -13.6% | 23.4% |
| Q1 26 | — | $-0.80 | ||
| Q4 25 | $0.18 | $-0.77 | ||
| Q3 25 | $-0.16 | $1.36 | ||
| Q2 25 | $-0.44 | $1.13 | ||
| Q1 25 | $-0.97 | $0.78 | ||
| Q4 24 | $-0.03 | $1.06 | ||
| Q3 24 | $-1.48 | $1.29 | ||
| Q2 24 | $-0.65 | $1.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $64.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $152.7M | $468.0M |
| Total Assets | $1.0B | $4.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $64.0M | ||
| Q4 25 | $583.8M | $64.0M | ||
| Q3 25 | $565.2M | $70.0M | ||
| Q2 25 | $545.5M | $50.0M | ||
| Q1 25 | $520.6M | $48.0M | ||
| Q4 24 | $535.6M | $103.0M | ||
| Q3 24 | $522.0M | $72.0M | ||
| Q2 24 | $561.5M | $70.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.5B | ||
| Q3 25 | — | $2.6B | ||
| Q2 25 | — | $2.5B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | — | $2.4B | ||
| Q2 24 | — | $2.4B |
| Q1 26 | — | $468.0M | ||
| Q4 25 | $152.7M | $468.0M | ||
| Q3 25 | $121.9M | $583.0M | ||
| Q2 25 | $103.7M | $570.0M | ||
| Q1 25 | $86.7M | $579.0M | ||
| Q4 24 | $90.9M | $650.0M | ||
| Q3 24 | $71.8M | $583.0M | ||
| Q2 24 | $99.2M | $623.0M |
| Q1 26 | — | $4.2B | ||
| Q4 25 | $1.0B | $4.2B | ||
| Q3 25 | $995.2M | $4.3B | ||
| Q2 25 | $964.0M | $4.3B | ||
| Q1 25 | $926.1M | $4.2B | ||
| Q4 24 | $931.4M | $4.2B | ||
| Q3 24 | $909.7M | $4.2B | ||
| Q2 24 | $919.2M | $4.2B |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.37× | ||
| Q3 25 | — | 4.43× | ||
| Q2 25 | — | 4.44× | ||
| Q1 25 | — | 4.29× | ||
| Q4 24 | — | 3.72× | ||
| Q3 24 | — | 4.19× | ||
| Q2 24 | — | 3.83× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $367.0M |
| Free Cash FlowOCF − Capex | $14.5M | $168.0M |
| FCF MarginFCF / Revenue | 6.9% | 50.3% |
| Capex IntensityCapex / Revenue | 5.6% | — |
| Cash ConversionOCF / Net Profit | 4.70× | — |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $437.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $367.0M | ||
| Q4 25 | $26.2M | $152.0M | ||
| Q3 25 | $34.9M | $86.0M | ||
| Q2 25 | $27.7M | $70.0M | ||
| Q1 25 | $-7.9M | $59.0M | ||
| Q4 24 | $19.2M | $134.0M | ||
| Q3 24 | $24.3M | $79.0M | ||
| Q2 24 | $11.8M | $1.0M |
| Q1 26 | — | $168.0M | ||
| Q4 25 | $14.5M | $136.0M | ||
| Q3 25 | $20.1M | $75.0M | ||
| Q2 25 | $17.3M | $58.0M | ||
| Q1 25 | $-17.3M | $52.0M | ||
| Q4 24 | $12.4M | $109.0M | ||
| Q3 24 | $15.5M | $71.0M | ||
| Q2 24 | $3.4M | $-6.0M |
| Q1 26 | — | 50.3% | ||
| Q4 25 | 6.9% | 40.7% | ||
| Q3 25 | 10.4% | 19.6% | ||
| Q2 25 | 9.3% | 14.6% | ||
| Q1 25 | -10.9% | 16.5% | ||
| Q4 24 | 7.5% | 32.4% | ||
| Q3 24 | 10.5% | 17.9% | ||
| Q2 24 | 2.3% | -1.6% |
| Q1 26 | — | — | ||
| Q4 25 | 5.6% | 4.8% | ||
| Q3 25 | 7.7% | 2.9% | ||
| Q2 25 | 5.6% | 3.0% | ||
| Q1 25 | 5.9% | 2.2% | ||
| Q4 24 | 4.2% | 7.4% | ||
| Q3 24 | 6.0% | 2.0% | ||
| Q2 24 | 5.7% | 1.9% |
| Q1 26 | — | — | ||
| Q4 25 | 4.70× | — | ||
| Q3 25 | — | 0.82× | ||
| Q2 25 | — | 0.80× | ||
| Q1 25 | — | 0.97× | ||
| Q4 24 | — | 1.58× | ||
| Q3 24 | — | 0.77× | ||
| Q2 24 | — | 0.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
WH
| Fee-related and other revenues | $334.0M | 100% |
| Management and other fees | $2.0M | 1% |
